Cibus CEO foretells gene editing and bioinformatics to target peanut allergens

December 09, 2019 | Case Study

Crop and livestock trait development with gene editing (GE) is on the mind of every business across the agriculture industry. Peter Beetham (CEO of Cibus) provided a recent and optimistic opinion in Scientific American. Cibus (Lux Take: Positive) is a well-funded GE trait developer employing gene repair oligonucleotides (GRON) to improve the precision of tools like TALEN and CRISPR/Cas by avoiding the associated repair errors. Cibus holds patents for the technology and is among the few developers with a commercialized gene-edited trait: sulfonylurea resistance in canola. Peter shared a view of overcoming human health issues associated with food through the confluence of GE and bioinformatics for crop development, starting with peanuts.

Related companies	Cibus

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Interested in Learning More?

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978